Activa Healthcare has changed its name to L&R


Flivasorb & Flivasorb adhesive

Twice as absorbant for highly exuding wounds

In detail

Highly exuding wounds such as leg ulcers are challenging to treat and can be distressing for patients. Excess exudate must be managed appropriately to prevent further deterioration of the wound and the surrounding skin.

Flivasorb is a high quality superabsorbent wound dressing, which absorbs twice as much as traditional absorbent dressings. Flivasorb retains this exudate, including the high level of harmful protease enzymes carried in chronic wound exudate, within the cellulose core.

Key benefits

  • absorbs and retains high volumes of exudate
  • extends wear time - reducing nursing time and cost
  • locks away harmful proteases and bacteria which could otherwise delay healing
  • protects against maceration - improving peri-wound skin
  • improves patients' quality of life

Flivasorb is effective under compression, meaning a combined approach to treatment can be taken to optimize healing potential.It is particularly effective under Actico which is ideal for chronic oedema where high levels of lymphorrea(wet leaky legs) are common.

Flivasorb has a silky smooth integrated contact layer, reducing the need for an additonal primary protection layer. It is cost effective - helping you manage exudate and your budget.

Flivasorb is available as an adhesive dressing (Flivasorb adhesive) combining the benefits of Flivasorb with a skin friendly, flexible adhesive membrane.

Features in detail

  • **Flat edges**

Conform well to healthy skin and facilitate application

    Flat edges

    Conform well to healthy skin and facilitate application

  • **Flexible wound contact layer**

Prevents adhesion to the wound

    Flexible wound contact layer

    Prevents adhesion to the wound

  • **Distribution layer**

Absorbed exudate is evenly distributed and quickly conducted into the absorbent core

    Distribution layer

    Absorbed exudate is evenly distributed and quickly conducted into the absorbent core

  • **Absorbent core with superabsorber**

Binds large amounts of wound exudate evenly in fixed superabsorber particles

    Absorbent core with superabsorber

    Binds large amounts of wound exudate evenly in fixed superabsorber particles

Flivasorb videos

Flivasorb Demonstration

Flivasorb is a pioneering, superabsorbent wound dressing, with twice as much absorption capacity in comparison to a traditional absorbent dressing.

Recommended e-learning modules


Exudate management with superabsorbent dressings. Flivasorb, its structure, mode of action, indications and contraindications.

Wound exudate

The role of exudate in wound management.

Related products

Common questions

  • What is a Superabsorbent Polymer (SAP)?

    Superabsorbent polymers (SAP) are polymers that can absorb several times their own weight in liquid (e.g. 20 times as much fluid).

    Chemically, a SAP is a long-chain polymer consisting of a polyacrylate (typically sodium polyacrylate). When a liquid comes into contact with a SAP it will attach to these polymer chains and form a complex network structure, resulting in visible swelling and gelling.

  • Can Flivasorb be used on infected wounds?

    Flivasorb will retain some pathogens in the dressing but it will not kill them and is primarily designed for exudate management. It should never be used as the only treatment for critically colonized or infected wounds.


Indications for use:

  • A variety of moderate to highly exuding wounds, including leg ulcers of various origins (venous/arterial), postoperative wounds healing by secondary intention, laparotomy wounds, fistulas, superficial partial thickness burns, pressure ulcers and dehisced surgical wounds. It can be used as a secondary dressing for cavity and sinus wounds.


  • Do not use Flivasorb on patients sensitive to any of the components of the dressing.
  • Do not use in cavity wounds as the dressing will expand upon absorbing exudate and may be difficult to remove
  • Do not use on lightly exuding or non-exuding wounds.
  • Do not use as the sole treatment for infected wounds as it will not kill the pathogens. It has a passive antimicrobial effect as it retains pathogens within the dressing. -Do not cut Flivasorb, as the contents of the dressing will come out.

Ordering codes

LR code PIP code Hospital code
Superabsorbent Dressing 10cm x 10cm 25810 343-4370 EME 026
Superabsorbent Dressing 10cm x 20cm 25811 343-4388 EME 027
Superabsorbent Dressing 20cm x 20cm 25812 343-4396 EME 028
Superabsorbent Dressing 20cm x 30cm 25910 345-0590 EME 029
Flivasorb Adhesive Superabsorbent Dressing 12cm x 12cm 30994 366-0826 EME 071
Flivasorb Adhesive Superabsorbent Dressing 15cm x 15cm 30995 366-0834 EME 072
Flivasorb Adhesive Superabsorbent Dressing 15cm x 25cm 30996 374-4661 EME 077

Clinical evidence

Devising a treatment programme to address the challenges of excess exudate

Wounds with high levels of exudate can incur increasing costs, both in time and resources and are deeply distressing for patients. It is imperative to heal these wounds as quickly as possible.

Author: Joy Tickle
Publication: JCN 2016, Vol 30, No 5
Date: January 30th, 2017


Evaluating a superabsorbent dressing (Flivasorb) in highly exuding wounds

An observational evaluation of 19 patients with highly exuding wounds using Flivasorb. Flivasorb is a super absorbent dressing that removes harmful exudate from the wound a promotes a healthy wound bed even under compression.

Author: Debby Verrall, Anna Coulborn, Cathie Bree-Aslan
Publication: British Journal of Nursing, March 2010
Date: March 1st, 2010


Superabsorbent dressings for copiously exuding wounds

15 patient study using Flivasorb, Flivasorb handled exudate, promoted healing and patient comfort.

Author: Nathalie Faucher, Helene Safar, Mylène Baret, Anne Philippe and Rachida Farid
Publication: British Journal of Nursing, 2012, Vol 21, No 12
Date: May 1st, 2012


Superabsorbent dressings under compression in Lymphoedema

Flivasorb can be used under compression bandages

Author: Justine Whitaker
Publication: EWMA 2012
Date: May 1st, 2012


Chronic oedema - a patient's perpetual journey for treatment

A 58 year old man with 18 years of lymphoedema. Clothes and slippers smelt offensive from lymphorrhea. Sleeping in a chair and not worn outdoor shoes for 3 years. Happy ending after Flivasorb and Actico , he was sleeping in his bed after 4 weeks and wearing normal shoes and clothes.

Author: Melanie Lewis NHS University Health Board, Swansea
Publication: Poster Presentation, EWMA Conference, Geneva - May 2010
Date: May 1st, 2010


Early intervention is the key to success

Why early intervention and diagnosis is so important in venous and lymphatic disease

Author: British Journal of Community Nursing
Publication: British Journal of Community Nursing
Date: August 1st, 2012


Sign up for our newsletter

Our newsletter features product news, new e-learning modules, and other resources relevant to your work as a healthcare professional.

Sign up